Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 8053 (MIR8053) is a human microRNA gene that produces a short (20-24 nucleotide) non-coding RNA. Like other microRNAs, it acts as a post-transcriptional regulator of gene expression by affecting mRNA stability and translation. MicroRNAs are transcribed as part of primary transcripts, processed by Drosha (to pre-miRNA) and Dicer (to mature miRNA), and incorporated into the RISC complex to repress target mRNAs[1][3]. The specific biological functions, disease roles, and validated targets of MIR8053 have not been characterized in detail. As with many microRNAs, its general class is important in varied cellular and disease processes; however, no interacting drugs, mechanisms of action for such drugs, or biomarker roles for MIR8053 are currently known in the literature or gene databases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 8053 (MIR8053).